RTTNews

What RTTNews does

RTTNews is a privately held digital media company founded in the late 1990s by Andrew Mariathasan in New York, operating a real-time news aggregation and distribution platform that covers finance, politics, health, entertainment, and technology across more than 50 countries. The core platform delivers free breaking business, economic and forex news, supported by an enterprise Financial Newswire service that the company reports is relied upon by major banks, brokerages, trading platforms and financial exchanges for redistribution into their own terminals and workflows.

The company's product portfolio spans three tiers. At the base is the ad-free news website with extensive categorical coverage plus a free RSS feed program (XML-based) for individual non-commercial use. At the consumer-investor tier, RTTNews operates premium subscription services — RTT Intelligent Investor for curated market intelligence, RTT Biotech Investor for FDA catalyst and clinical trial tracking across 500+ biotech companies (priced at $99/month after a 7-day trial, discounted from $299/month), and specialty offerings including Emerging Biostocks, Under The Radar, and Short-Term Investor. At the enterprise tier, the company licenses newswires, RSS feeds, content syndication, digital signage content and radio news services to financial institutions, websites, news terminals, databases, and broadcast stations.

Monetization rests on three streams: recurring premium subscriptions (Biotech Investor, Intelligent Investor and related services), B2B content licensing royalties (newswires, feeds, syndication, digital signage, radio services), and freemium RSS distribution that funnels readers toward paid products. The technology stack is a proprietary real-time editorial aggregation and distribution platform with XML-based syndication; no public API, AI/ML features, or developer SDKs are offered. The company is lean (11-50 employees), founder-controlled under Andrew Mariathasan with technology direction under Bharat Motwani, and operates with no disclosed institutional funding, parent company, or M&A activity.

Name

RTTNews

Legal name

RTTNews

Website

https://rttnews.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

11–50 employees

Short description

RTTNews is a privately held digital newswire founded in the late 1990s that aggregates real-time business, financial, and biotech news across 50+ countries, monetizing through premium investor subscriptions (Biotech Investor, Intelligent Investor), B2B content licensing to banks, brokerages and exchanges, and free RSS syndication.

Ownership category

akta.pro rank

Product category

Financial News and Market Intelligence

NAICS

Newspaper, Periodical, Book, and Directory Publishers (5131), Periodical Publishers (513120), Broadcasting and Content Providers (516)

SIC

Telegraph & Other Message Communications (4822), Miscellaneous Publishing (2741)

akta.pro primary industry

News Agencies & Wire Services (General & Specialized) (MPAJADAE)

akta.pro secondary industries

Business, Financial & Trade News Publishers (MPAJADAC), Syndication, Licensing & Content Partnerships (Columns, Features, Photos) (MPAJADAI), Data Journalism & News Intelligence Publishers (Indexes, Election/Market Data) (MPAJADAK)

Keywords

• Financial newswire services
• Biotech investor intelligence
• Content licensing syndication
• Real-time market news
• Premium investor subscriptions

Headquarters

HQ city

Buffalo

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Digital Commerce or Content

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Premium Subscriptions: Subscription-based premium services including RTT Intelligent Investor and Biotech Investor providing specialized market intelligence, FDA catalyst alerts, and biotech analysis for investors and traders.
2. Content Licensing: Licensing of news content including Newswires & Feeds, Content Syndication, Digital Signage Services, and Radio News Services to financial institutions, websites, news terminals, databases, radio stations, TV stations and other media outlets.
3. RSS Feeds: Free RSS feed distribution for individual non-commercial use, with commercial feed licensing available through content licensing services.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

RTTNews aggregates and distributes real-time business, economic, breaking, and forex news across more than 50 countries via its own publishing platform, premium subscription investor intelligence products, and enterprise content licensing (newswires, RSS feeds, content syndication, digital signage, and radio news services). Its commercial focus is selling real-time financial and biotech news to investors, financial institutions, and media outlets.

Product overview

RTTNews operates as a digital media news aggregation and distribution company offering a multi-tiered platform approach consisting of a core free news platform delivering real-time business, economic, breaking news, and forex coverage across over 50 countries, supplemented by premium subscription services including RTT Intelligent Investor for general market intelligence, RTT Biotech Investor for biotech-specific catalyst tracking (FDA decisions, clinical trials), and specialty services like Emerging Biostocks, Under The Radar, and Short-Term Investor. The company also provides enterprise content licensing services including RSS feeds, newswires, content syndication, digital signage, and radio news services to financial institutions, websites, news terminals, and media outlets, along with research tools such as FDA Drug Approval Calendars and Clinical Trial Calendars.

Differentiator

Problem solved

Functional benefit

Brands

• RTT Intelligent Investor: Premium subscription service providing daily filtered market intelligence, surfacing stocks with real upside potential before the broader market reacts.
• RTT Biotech Investor
• RTTNews RSS Feeds

Products and services

• RTTNews Platform Real-time business, economic, breaking news, and forex news aggregation and distribution platform covering over 50 countries across finance, politics, health, entertainment, and technology.
• RTT Intelligent Investor Daily filtered market intelligence premium subscription surfacing stocks with real upside potential before the broader market reacts, featuring curated actionable analysis and early catalyst alerts for active investors and traders.
• RTT Biotech Investor

Quantifiable outcome

• Coverage of 500+ biotech companies with FDA catalyst tracking
• +1 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Benzinga: Benzinga is a direct peer — a digital financial news publisher offering real-time market news, premium subscription services for traders and investors, and content licensing, overlapping directly with RTTNews' Intelligent Investor and Biotech Investor offerings.
• Business Wire: Business Wire is a direct peer in newswire and content syndication services, distributing corporate and financial news to media terminals, financial institutions, and websites — directly comparable to RTTNews' content licensing business.
• PR Newswire (Cision): PR Newswire is a direct peer in news/content distribution and syndication, selling newswire feeds and content licensing to media outlets, websites, and terminals — the same enterprise channels RTTNews targets.
• Dow Jones Newswires: Dow Jones Newswires is a direct peer — a real-time financial newswire service distributed to banks, brokerages, trading platforms, and financial exchanges, competing head-to-head with RTTNews' Financial Newswire for enterprise content licensing contracts.
• Zacks Investment Research: Zacks is a direct peer — a subscription-based investment research and stock-picking service targeting retail and professional investors, overlapping with RTT Intelligent Investor, Emerging Biostocks, and Under The Radar premium services.

Broad incumbents

• Yahoo Finance: Yahoo Finance is a broad incumbent in free real-time financial news, market data, and investor content, competing with RTTNews' free news platform while also serving as a potential distribution channel for syndicated content.
• Investing.com: Investing.com is a broad incumbent in global real-time financial news, forex, and market analysis, overlapping significantly with RTTNews' forex, market analysis, and breaking news coverage across 50+ countries.

Emerging players

• AlphaSense: AlphaSense is an emerging player in AI-powered market and business intelligence, including earnings transcripts and news search, increasingly competing for the same enterprise research budgets that RTTNews' financial newswire serves.
• TipRanks: TipRanks is an emerging player offering analyst-tracking, stock-rating aggregation, and investment intelligence tools, partially overlapping with RTTNews' catalyst-driven investor intelligence products.
• Seeking Alpha: Seeking Alpha is an emerging player in subscription-based investment research and market analysis with strong retail investor reach, partially overlapping with RTTNews' premium investor services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/rttnews
• Facebookfacebook.com/RTTTopStories
• LinkedInlinkedin.com/company/rttnews

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RTTNews